```html

Methanol Toxicity – Comprehensive Medical Guide

Overview

Methanol (also called wood alcohol) is a colorless, volatile liquid found in industrial solvents, windshield‑washer fluid, some antifreeze formulations, and illegally‑distilled alcoholic beverages. When ingested, inhaled, or absorbed through the skin in sufficient amounts, methanol is metabolized into toxic compounds that can cause severe metabolic acidosis, visual loss, and death.

Who it affects: Anyone can be exposed, but the most common cases involve:

• Adults who consume adulterated or “bootleg” spirits.
• Workers in manufacturing, roofing, or fuel‑additive industries without proper personal protective equipment (PPE).
• Individuals using homemade hand‑sanitizers or cleaning products containing methanol.

Prevalence: In the United States, methanol poisoning accounts for roughly 1–2 % of all acute alcohol‑related poisonings, translating to 300–400 emergency department (ED) visits per year [1]. Outbreaks are reported worldwide when illicit alcohol production surges, especially in low‑resource settings.

Symptoms

Symptoms develop in three phases: (1) a latent period (6–30 h after exposure), (2) metabolic acidosis, and (3) visual/neurologic injury. The timing and severity depend on dose, route of exposure, and individual susceptibility.

Early (Latent) Phase

• Headache – dull, often described as “pressure”.
• Dizziness or vertigo – may be mistaken for ethanol intoxication.
• Nausea & vomiting – usually non‑bloody.
• Abdominal pain – epigastric or diffuse.
• Flu‑like malaise – fatigue, mild fever.

Intermediate Phase (Metabolic Acidosis)

• Rapid breathing (Kussmaul respirations) – body’s attempt to buffer acid.
• Confusion, agitation or lethargy – due to CNS depression.
• Hypotension – may progress to shock.
• Seizures – uncommon but possible in severe cases.

Late Phase (Ocular & Neurologic)

• Visual disturbances – blurred vision, “snowfield” vision, photophobia.
• Decreased visual acuity – may progress to complete blindness (optic nerve edema, “pseudocystic” changes).
• Permanent optic neuropathy – risk rises if treatment is delayed >12 h.
• Neuropathy – peripheral numbness, ataxia.
• Coma – in fulminant cases.

Because the latent phase can be asymptomatic, many patients present only after the metabolic or visual manifestations appear.

Causes and Risk Factors

Sources of Exposure

• Ingestion – the most common route; includes drinking contaminated spirits, accidental consumption of windshield‑washer fluid, or ingestion of methanol‑containing hand sanitizer.
• Inhalation – occupational exposure to vapors from solvents, fuel additives, or improperly vented methanol stills.
• Dermal absorption – prolonged skin contact with methanol‑based products, especially without gloves.

Risk Factors

• Working in industries that use methanol (e.g., paint remover, antifreeze, formaldehyde production).
• Living in regions where illicit alcohol is prevalent.
• Alcohol dependence – individuals may substitute methanol‑contaminated drinks for ethanol.
• Poor ventilation or lack of PPE during industrial work.
• Renal or hepatic impairment – reduced ability to metabolize toxins.

Diagnosis

Clinical Evaluation

Diagnosis begins with a high index of suspicion based on history (exposure) and the classic triad of metabolic acidosis, visual symptoms, and an anion gap >12 mEq/L.

Laboratory Tests

• Arterial blood gas (ABG) – determines pH (often <7.35) and bicarbonate level.
• Serum electrolytes – calculate anion and osmolar gaps.
• Serum methanol level – measured by gas chromatography; >20 mg/dL is generally considered toxic, but treatment may start before results return.
• Lactate – often elevated due to tissue hypoxia.
• Renal function tests – creatinine and BUN to assess kidney injury.

Imaging & Other Studies

• CT or MRI of the brain – helps rule out stroke or hemorrhage if neurological deficits are prominent.
• Ophthalmologic exam – fundoscopy may reveal optic disc edema or hyperemia.

Because serum methanol results can take hours, most protocols treat based on clinical suspicion and the presence of metabolic acidosis with an elevated anion gap.

Treatment Options

Immediate Management

• Airway, Breathing, Circulation (ABCs) – ensure adequate oxygenation and hemodynamic support.
• Intravenous (IV) fluids – isotonic saline to correct volume depletion and improve renal clearance.

Antidotal Therapy

The cornerstone of treatment is blocking methanol metabolism.

• Fomepizole (4‑phosphorodiamidate) – 15 mg/kg loading dose over 30 min, then 10 mg/kg every 12 h (adjust for renal failure). It inhibits alcohol dehydrogenase, preventing formation of the toxic metabolites formaldehyde and formic acid [2].
• Ethanol – alternative when fomepizole is unavailable; loading dose 0.8 g/kg IV, then 100 mg/kg/hr infusion to maintain blood ethanol 100–150 mg/dL. Requires intensive monitoring for hypoglycemia and respiratory depression.

Acid‑Base Correction

• Sodium bicarbonate IV – administered to raise serum pH >7.30 and reduce formic acid toxicity.

Hemodialysis

Indicated when any of the following are present (per the American Academy of Clinical Toxicology):

• Serum methanol >50 mg/dL.
• Severe metabolic acidosis (pH <7.25) despite bicarbonate therapy.
• Visual disturbances or renal failure.
• Persistent high anion gap after antidote therapy.

Hemodialysis rapidly removes both methanol and formic acid, correcting acidosis and preventing irreversible optic nerve damage.

Supportive Care

• Thiamine 100 mg IV q8h – may aid in mitochondrial metabolism of formic acid.
• Riboflavin 10 mg IV q12h – sometimes used adjunctively.
• Frequent glucose monitoring (especially with ethanol therapy).

Long‑Term Follow‑Up

Patients who survive the acute phase should see an ophthalmologist and a neurologist within 1–2 weeks to assess for residual visual or peripheral nerve deficits.

Living with Methanol Toxicity

Although many patients recover fully when treated promptly, some experience lingering effects. Below are practical strategies for daily life after an acute episode.

Medical Follow‑Up

• Schedule ophthalmology visits every 3–6 months for the first year.
• Repeat serum chemistries and anion‑gap checks until stable.
• Consider neuro‑psychological evaluation if memory or concentration problems persist.

Lifestyle Adjustments

• Avoid alcohol – ethanol can interfere with the metabolism of methanol‑derived metabolites and mask symptoms of recurrence.
• Hydration – aim for ≥2 L of water daily, unless contraindicated, to facilitate renal clearance.
• Protect eyes – wear UV‑blocking sunglasses; avoid bright, flickering lights that may exacerbate visual discomfort.
• Nutrition – a balanced diet rich in B‑vitamins (especially thiamine) supports mitochondrial function.
• Occupational safety – if working with methanol, ensure proper ventilation, wear gloves, goggles, and respiratory protection.

Psychosocial Support

Experiencing poisoning can be traumatic. Consider counseling, support groups, or substance‑use treatment programs if alcohol dependence contributed to exposure.

Prevention

• Labeling & Storage – keep methanol‑containing products in clearly marked, child‑proof containers away from food and drinks.
• Workplace Controls – enforce OSHA‑mandated ventilation, provide PPE, and conduct regular air‑monitoring.
• Public Education – community campaigns about the dangers of illicit alcohol, especially in regions with known outbreaks.
• Regulation of Hand Sanitizers – only purchase products approved by the FDA or WHO; avoid homemade formulations that may contain methanol.
• Emergency Packaging – keep calcium gluconate or fomepizole kits (where available) in industrial settings for rapid response.

Complications

If diagnosis or treatment is delayed, methanol toxicity can lead to:

• Permanent vision loss – up to 30 % of untreated cases develop blindness [3].
• Neurological sequelae – basal ganglia lesions, ataxia, peripheral neuropathy.
• Renal failure – acute tubular necrosis from severe acidosis.
• Cardiovascular collapse – shock, arrhythmias.
• Multi‑organ failure – especially when hemodialysis is not initiated.
• Psychiatric consequences – depression or anxiety secondary to visual impairment.

When to Seek Emergency Care

References

1. Centers for Disease Control and Prevention. Methanol Poisoning Data, 2022.
2. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. Fomepizole Antidote Guidelines. 2020.
3. World Health Organization. Methanol Poisoning Fact Sheet. Updated 2021.
4. Mayo Clinic. Methanol poisoning symptoms and treatment.
5. Cleveland Clinic. Methanol (Wood Alcohol) Poisoning.

```